Clinical trial NCT04072874 - References

Leishmaniasis, Cutaneous — Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.

Citation(s)

•   Almeida OL, Santos JB
  Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review. An Bras Dermatol. 2011 May-Jun;86(3):497-506. Review. English, Portuguese.
•   Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team
  Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
•   Blum J, Desjeux P, Schwartz E, Beck B, Hatz C
  Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother. 2004 Feb;53(2):158-66. Epub 2004 Jan 16. Review.
•   Blum J, Lockwood DN, Visser L, Harms G, Bailey MS, Caumes E, Clerinx J, van Thiel PP, Morizot G, Hatz C, Buffet P
  Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. Int Health. 2012 Sep;4(3):153-63. doi: 10.1016/j.inhe.2012.06.004.
•   Croft SL, Seifert K, Yardley V
  Current scenario of drug development for leishmaniasis. Indian J Med Res. 2006 Mar;123(3):399-410. Review.
•   Herwaldt BL
  Leishmaniasis. Lancet. 1999 Oct 2;354(9185):1191-9. Review.
•   Lee SA, Hasbun R
  Therapy of cutaneous leishmaniasis. Int J Infect Dis. 2003 Jun;7(2):86-93. Review.
•   López L, Robayo M, Vargas M, Vélez ID
  Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials. 2012 May 17;13:58. doi: 10.1186/1745-6215-13-58. Erratum in: Trials. 2017 Sep 1;18(1):408.
•   Organizacion Panamerica de la Salud, OPS
  Leishmaniasis en las Americas: Recomendaciones para el tratamiento. 2013. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=22226&Itemid
•   Pearson, R
  D., and A. de Querez Sousa. 1995 Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniaisis. p. 2428-2442. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.) Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
•   Reveiz L, Maia-Elkhoury AN, Nicholls RS, Romero GA, Yadon ZE
  Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update. PLoS One. 2013 Apr 29;8(4):e61843. doi: 10.1371/journal.pone.0061843. Print 2013. Review.
•   Silva NS, Muniz VD
  [Epidemiology of American tegumentary leishmaniasis in the State of Acre, Brazilian Amazon]. Cad Saude Publica. 2009 Jun;25(6):1325-36. Portuguese.
•   Soto J, Rea J, Balderrama M, Toledo J, Soto P, Valda L, Berman JD
  Efficacy of miltefosine for Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg. 2008 Feb;78(2):210-1.
•   Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV
  Recent advances in leishmaniasis treatment. Int J Infect Dis. 2011 Aug;15(8):e525-32. doi: 10.1016/j.ijid.2011.03.021. Epub 2011 May 24. Review.
•   Velasco-Castrejon O, Walton BC, Rivas-Sanchez B, Garcia MF, Lazaro GJ, Hobart O, Roldan S, Floriani-Verdugo J, Munguia-Saldana A, Berzaluce R
  Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg. 1997 Sep;57(3):309-12.
•   Vélez I, López L, Sánchez X, Mestra L, Rojas C, Rodríguez E
  Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg. 2010 Aug;83(2):351-6. doi: 10.4269/ajtmh.2010.10-0060.
•   Votýpka J, Kasap OE, Volf P, Kodym P, Alten B
  Risk factors for cutaneous leishmaniasis in Cukurova region, Turkey. Trans R Soc Trop Med Hyg. 2012 Mar;106(3):186-90. doi: 10.1016/j.trstmh.2011.12.004. Epub 2012 Jan 26.
•   WHO technical report series; no
  949. Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010.

Evaluation of the Safety and Clinical Activity of Curaleish Lotion and Cream in the Topical Treatment of Cutaneous Leishmaniasis in Colombia

Details for clinical trial NCT04072874